{"id":13928,"date":"2019-07-11T09:00:03","date_gmt":"2019-07-11T08:00:03","guid":{"rendered":"https:\/\/mileon.wordpress.com\/?p=13928"},"modified":"2019-07-11T09:00:03","modified_gmt":"2019-07-11T08:00:03","slug":"sesion-bibliografica-nejm-vitamina-d-canaglifozina-y-semaglutida-en-diabetes-tipo-2","status":"publish","type":"post","link":"https:\/\/www.icscyl.com\/mileon\/residentes\/2019-07-11\/sesion-bibliografica-nejm-vitamina-d-canaglifozina-y-semaglutida-en-diabetes-tipo-2\/","title":{"rendered":"Sesi\u00f3n bibliogr\u00e1fica NEJM: vitamina D, canaglifozina y semaglutida en diabetes tipo 2"},"content":{"rendered":"<p><img loading=\"lazy\" decoding=\"async\" class=\"alignright size-thumbnail wp-image-9118\" src=\"https:\/\/mileon.files.wordpress.com\/2015\/12\/nejm_logo2011.png?w=150\" alt=\"Nejm_logo2011\" width=\"150\" height=\"150\" \/>La sesi\u00f3n bibliogr\u00e1fica de residentes mayores del pasado mes correspondi\u00f3 a la Dra. Mart\u00ednez (R4) que repas\u00f3 los siguientes art\u00edculos publicados en la revista New England Journal of Medicine:<\/p>\n<ul>\n<li>Vitamin D supplementation and prevention of type 2 diabetes<\/li>\n<li>Canaglifozin and renal outcomes in type 2 diabetes and nephropathy<\/li>\n<li>Oral semaglutide and cardiovascular outcomes in patients with type 2 diabetes<\/li>\n<\/ul>\n<p>Su presentaci\u00f3n se encuentra disponible en este <a href=\"https:\/\/mileon2.files.wordpress.com\/2019\/07\/sesion-bibliografica-17-junio-2019.pdf\">enlace.<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>La sesi\u00f3n bibliogr\u00e1fica de residentes mayores del pasado mes correspondi\u00f3 a la Dra. Mart\u00ednez (R4) que repas\u00f3 los siguientes art\u00edculos publicados en la revista New England Journal of Medicine: Vitamin D supplementation and prevention of type 2 diabetes Canaglifozin and renal outcomes in type 2 diabetes and nephropathy Oral semaglutide and cardiovascular outcomes in patients [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[721],"tags":[],"class_list":["post-13928","post","type-post","status-publish","format-standard","hentry","category-residentes"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/posts\/13928","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/comments?post=13928"}],"version-history":[{"count":0,"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/posts\/13928\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/media?parent=13928"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/categories?post=13928"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/tags?post=13928"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}